| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 08/04/2004 | EP1442011A1 Zwitterionic imides |
| 08/04/2004 | EP1356153B1 Method of treating fibrous substrates with alkylated fluorochemical oligomers and treated fibrous substrates |
| 08/04/2004 | EP1296945B1 Sulfonamide derivatives |
| 08/04/2004 | EP1157001B1 Oxamic acids and derivatives as thyroid receptor ligands |
| 08/04/2004 | EP0942900A4 Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines |
| 08/04/2004 | CN1518683A Method for purifying free-base p-phenylenediamine-type photographic color developers |
| 08/04/2004 | CN1518534A Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 08/04/2004 | CN1160323C New benzenesulfonylamine derivatives, process for preparating them and pharmaceutical compositions containing them |
| 08/03/2004 | US6770648 Antidiabetic agents |
| 07/29/2004 | WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents |
| 07/29/2004 | WO2004062601A2 Antibacterial agents |
| 07/29/2004 | WO2004033422A3 Modulation of anxiety through blockade of anandamide hydrolysis |
| 07/29/2004 | WO2003101382A3 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 07/29/2004 | US20040147745 Novel compounds and compositions as protease inhibitors |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147612 Glutamate receptors; psychological and central nervous system disorders ;Alzheimer's ; cognition activators; attention deficit disorders; hyperactivity; antidepressants; Parkinson's disease; strokes |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147575 Hypotensive agents; cardiovascular disorders |
| 07/29/2004 | US20040147570 Substituted 1 and 2-naphthol mannich bases |
| 07/29/2004 | US20040147559 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/29/2004 | DE10012618B4 Weichmacher für Kunststoffe Plasticizers for plastics |
| 07/29/2004 | CA2851462A1 Antibacterial agents |
| 07/29/2004 | CA2512582A1 Antibacterial agents |
| 07/28/2004 | EP1440965A1 Antimicrobial compounds |
| 07/28/2004 | EP1440057A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors |
| 07/28/2004 | EP0990645B1 Novel sulfonamide derivatives |
| 07/28/2004 | EP0931065B1 use of NITRIC ESTER DERIVATIVES IN the treatment of URINARY INCONTINENCE |
| 07/28/2004 | CN1515548A Oxaminic acid used as thyroid gland receptor ligand and its derivative |
| 07/28/2004 | CN1159293C 5-aroylnaphthalene derivatives |
| 07/28/2004 | CN1159292C Aryl substitued cyclic amines as selective dopamine D3 ligands |
| 07/27/2004 | US6767922 IL-8 receptor antagonists |
| 07/22/2004 | WO2003014296A3 A group of novel anti-cancer compounds with specific structure |
| 07/22/2004 | US20040143020 Psychological and central nervous system disorders |
| 07/22/2004 | US20040142993 Viricides |
| 07/22/2004 | US20040142989 Viricides |
| 07/22/2004 | US20040142986 Controlling transforming growth facor; artificial skin; wound healing agents |
| 07/22/2004 | US20040142983 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 07/22/2004 | US20040142982 Urea derivatives as integrin alpha 4 antagonists |
| 07/22/2004 | US20040142981 Sterilization, antiseptics for bacteria infections |
| 07/22/2004 | US20040142975 Antiarthritic agents; canticancer agents; antitumor agents; cardiovascular diosrders; skin diosrders; vision defects; antiinflammatory agents |
| 07/22/2004 | US20040142953 Inhibitors of histone deacetylase |
| 07/22/2004 | US20040142878 N-cycloalkylglycines as HIV protease inhibitors |
| 07/21/2004 | EP1438404A2 Inhibition of specific histone deacetylase isoforms |
| 07/21/2004 | EP1438293A2 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 07/21/2004 | EP1438287A1 Aromatic imide and aromatic methylidynetrissulfonyl compounds and method for making same |
| 07/21/2004 | EP1438286A1 Method for producing arylsuphonic acid isocyanates |
| 07/21/2004 | EP1144369B1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 07/21/2004 | EP1077694B1 Aryl nitrone therapeutics for the treatment of inflammatory bowel disease |
| 07/21/2004 | CN1514824A Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents |
| 07/21/2004 | CN1514823A 草酸衍生物 Oxalic acid derivatives |
| 07/21/2004 | CN1158264C Metabotropic glutamate receptor antagonists for treating central nervous system disease |
| 07/20/2004 | US6765115 Intermediates to sulfonyl imides; salt formation; purity |
| 07/20/2004 | US6765023 Use of substituted N, N-disubstituted reverse aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 07/15/2004 | WO2004058736A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058709A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058697A1 4-nitro-2-[(4'-methoxy)-phenoxy]-methanesulfonanilide derivates and their pharmaceutical use |
| 07/15/2004 | WO2004058694A1 A process for the preparation of enantiomerically pure (r) or (s)-5-(2-aminopropyl)-2-methoxybenzenesulfonamide |
| 07/15/2004 | WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/15/2004 | WO2004058683A2 Ligands of adenine nucleotide translocase (ant) and compositions and methods related thereto |
| 07/15/2004 | WO2004058164A2 Asthma and allergic inflammation modulators |
| 07/15/2004 | WO2004039753A3 Phenyl compounds |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138502 Ph-dependent nmda receptor antagonists |
| 07/15/2004 | US20040138468 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/15/2004 | US20040138275 Serine protease inhibitor; cardiovascular disorders |
| 07/15/2004 | US20040138255 Modulate cell signal transduction; anticarcinogenic agents; antidiabetic agents; osteoporosis |
| 07/15/2004 | US20040138206 Novel sulfonamide derivatives, intermidiate thereof, its preparation methods, and pharmaceutical composition comprising the same |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437132A1 Use of nitric ester derivatives in the manufacture of a medicament for the treatment of gastrointestinal tumors |
| 07/14/2004 | EP1436258A2 Ph-dependent nmda receptor antagonists |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1436252A1 Hydroxyfattysulfonic acid analogs |
| 07/14/2004 | EP1435936A1 5'-carbamoyl-1,1-biphenyl-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435933A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1435894A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 07/14/2004 | EP1237858B1 Method for preparing imides from sulfonyl fluorides |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1133465B1 Amphiphilic polyamine compounds |
| 07/14/2004 | CN1512982A Novel polyamine analogues as therapeutic and diagnostic agents |
| 07/14/2004 | CN1511828A Sufonic aniline derivatives and their medicinal use |
| 07/14/2004 | CN1157372C Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as medicament and pharmaceutical preparations containing the same |
| 07/14/2004 | CN1157365C Monoamine reuptake inhibitors for treatment of CNS disorders |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/13/2004 | US6762198 Such as 2-((4'-methoxy-(1,1'-biphenyl)-4-yl)-sulfonyl)-amino-3-(2-phenoxymethyl -(1,3)dioxan-2-yl)propionic acid |
| 07/13/2004 | US6762178 For use in treatment of disease conditions mediated by tnf-alpha, such as rheumatoid arthritis, osteoarthritis, sepsis, aids, ulcerative colitis, multiple sclerosis, crohn's disease, degenerative cartilage loss |
| 07/13/2004 | CA2348882C Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
| 07/13/2004 | CA2268684C Process for alkylating hindered sulfonamides |
| 07/08/2004 | WO2004056764A1 Aromatic derivatives as hiv aspartyl protease inhibitors |
| 07/08/2004 | WO2004056319A2 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | WO2003103599A3 Caspase-1 inhibitors and methods for their use |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132800 aminomethyl- or ethyl-substituted indoles, tetrahydrocarbazoles and tetrahydropyrido[1,2-a]indoles |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040131544 Positron emission tomography ; multistage process; medical diagnosis |
| 07/08/2004 | CA2509881A1 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/07/2004 | EP1434585A1 Alkyne matrix metalloproteinase inhibitors |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/07/2004 | CN1156451C Betz 2-adrenoceptor agonists |